The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...

FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...

Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th American Society of Hematology Annual Meeting Received ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

Dhanashree Verma has taken up pottery therapy calling it therapeutic and encouraging others to explore creative outlets for ...

In a recent clip, Dhanashree shared that she has been trying her hands at pottery and called it ‘therapeutic’. This has added ...

Dhanashree Verma addressed rumors about her relationship with Yuzvendra Chahal by sharing her pottery class experience on ...

Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

Credit: fizkes/Shutterstock. Sen-Jam Pharmaceutical has reported positive preliminary outcomes from its Phase II trial of SJP-002C, its new therapeutic, aimed at treating upper respiratory infections, ...

Health experts are concerned Australians may be relying too heavily on cosmetic "sun protection" products instead of regulated, therapeutic sunscreens to protect themselves from harmful UV radiation.